ADAM17 and cancer: We decided to build on these findings by assessing whether the adhesion of several other human cell lines derived either from solid tumors (“cancer cell lines”) or hematological malignancies (“leukocytic cell lines”) to immobilized recombinant ADAM17-Fc was also mediated by integrin α5β1.